Concerns on new diabetes medicine

Published: 2007-10-16 06:59:00

Updated: 2007-10-16 06:59:00

Worries are raised about the safety of a new diabetes medicine Januvia (sitagliptin phosphate), a drug expected to be big sellers for MSD Korea. But it is unclear if the concerns are justified or just the result of a hair-trigger tendency concerning drug safety on the part of doctors.

In a pr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK